Adrenal incidentalomas: A seven-year follow-up single-center experience
Open Access
- 1 December 2023
- journal article
- research article
- Published by University of Nis Faculty of Medicine in AFMN Biomedicine
- Vol. 41 (2) , 252-262
Abstract
Adrenal incidentalomas (AIs) are defined as tumours revealed during imaging procedures of abdomen or abdominal laparotomy, performed in patients without previous suspicion for adrenal disease. This study was conducted to evaluate morphological and functional features of AIs seven years after the initial diagnosis. Thirty-eight AI patients were monitored for seven years, with CT scans used for morphological follow-up. Hormonal activity assessments included basal cortisol levels, adrenocorticotropic hormone, overnight Dexamethasone suppression test, plasma or urinary metanephrines, vanillymandelic acid, electrolytes, hematocrit, acid-base status, oral glucose tolerance test, and chromogranin A. Functional activity was confirmed in six patients, with mild autonomous cortisol secretion (MACS) detected in two patients. Nine patients underwent adrenalectomy. Histopathological examination revealed hormonal activity in six cases, adrenocortical carcinoma was found in one patient, while secondary deposits from bronchial carcinoma were detected in one patient. Among the remaining 29 patients observed for the first year, tumor size remained stable. After seven years, two patients experienced tumor enlargement ≥ 1 cm, along with the development of MACS on endocrine evaluation. Adrenalectomy was recommended for one patient due to tumor size exceeding 4 cm. The initial adrenal incidentaloma (AI) evaluation must include comprehensive diagnostic procedures for surgical consideration. Subsequent follow-up should include CT imaging after 12 months to monitor the tumor growth. Although mild autonomous cortisol secretion does not tend to progress to overt Cushing's syndrome, it can develop in patients initially considered to have hormonally inactive tumor. Our findings suggest that even small adrenal masses (< 4 cm) can enlarge over seven years, potentially evolving into MACS. Therefore, regular long-term monitoring every 5 - 7 years is recommended.Keywords
This publication has 17 references indexed in Scilit:
- European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal TumorsEuropean Journal of Endocrinology, 2023
- The Lateralizing Asymmetry of Adrenal AdenomasJournal of the Endocrine Society, 2018
- A review of the anatomy and clinical significance of adrenal veinsClinical Anatomy, 2014
- The clinical significance of adrenal incidentalomasEuropean Journal of Clinical Investigation, 2011
- The Incidentally Discovered Adrenal MassNew England Journal of Medicine, 2007
- Evaluation and Management of the Incidental Adrenal MassBaylor University Medical Center Proceedings, 2003
- Evaluation and Management of Adrenal MassesCancer Control, 2002
- Adrenocortical Tumors*The Journal of Clinical Endocrinology & Metabolism, 1997
- Adrenal Incidentaloma: An Overview of Hormonal Data from the National Italian Study GroupHormone Research, 1997
- Adrenal cortical carcinoma a study of 77 casesCancer, 1983